Immunotherapy strategies for EGFR-mutated advanced NSCLC after EGFR tyrosine-kinase inhibitors failure

Overview of attention for article published in Frontiers in oncology, October 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 2 X users

reddit: 1 Redditor

Readers on

mendeley: 1 Mendeley

Summary X Reddit

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,536 followers.

RT @FrontOncology: New research: Immunotherapy strategies for EGFR-mutated advanced NSCLC after EGFR tyrosine-kinase inhibitors failure: Ba…

13 Oct 2023

Reply Repost Favourite

New research: Immunotherapy strategies for EGFR-mutated advanced NSCLC after EGFR tyrosine-kinase inhibitors failure: Background This study aimed to investigate the efficacy of immunotherapy, as monotherapy or in combination, comparing to… #oncology https

10 Oct 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.